Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01331798
Other study ID # PRO-100-0002
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received April 6, 2011
Last updated April 7, 2011
Start date December 2009
Est. completion date May 2010

Study information

Verified date April 2011
Source Cohera Medical, Inc.
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

A blinded, prospective, randomized trial in 40 abdominoplasty cases at three sites to study the safety and the preliminary efficacy of TissuGlu®, a novel surgical adhesive, in the management of wound drainage during abdominoplasty procedures.


Description:

Background: Fluid accumulation in dissected tissue planes has been a longstanding problem following surgical procedures. The common use of closed suction drains has been associated with infection risk, wound healing complications, additional scarring, and patient discomfort. Additionally, seroma formation after drain removal often requires invasive treatment. Therapies that can reduce fluid accumulation and decrease the need for drains will have a positive impact on surgical practice.

Objective: To study the safety and the preliminary efficacy of a TissuGlu®, a novel surgical adhesive, in the management of wound drainage during abdominoplasty procedures.

Material & Methods: A blinded prospective randomized trial compared drain fluid output (volume) and complication profile in 40 subjects undergoing abdominoplasty with (n=20) or without (n=20) the use of a urethane based adhesive. The TissuGlu® adhesive, which required no mixing or preparation, was administered to the abdominal wall using a custom drop tip applicator prior to closure of the abdominoplasty flap. Two Blake® drains connected to J-VAC suction reservoirs were placed in the wound.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 2010
Est. primary completion date May 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Be at least 20 years of age;

- Be in good general health in the opinion of the Investigator with no conditions that would significantly impact wound healing as determined by medical history and review of recent concomitant medications;

- Be scheduled for at least one full thickness surgical incision of at least 20cm in length as part of elective abdominoplasty requiring the placement of sutures in the superficial fascia and subcutaneous tissue to relieve skin tension prior to final skin closure, Surgeon must use electrocautery in the procedure;

- Be willing to follow instructions for incision care, comply with schedule for wound drainage volume measurements, and follow guidelines related to resumption of daily activities;

- Agree to return for all follow-up evaluations specified in this protocol;

- Agree not to schedule any additional elective surgical procedures that involve an incision until their participation in this study is complete; and

- Sign the informed consent.

Exclusion Criteria:

- Anesthesia Risk judged to be higher than ASA2

- Previous Abdominoplasty

- Have severe co-morbid conditions that pose a high risk for surgery and adequate recovery (e.g., heart disease)

- Any condition involving compromised vascular flow to the abdominal wall tissue. Prior abdominal scars, especially subcostal scars, will be a relative contraindication and judged on a case by case basis by the surgeon investigator.

- Any condition known to effect wound healing, such as collagen vascular disease

- Current active tobacco use, including smokeless (chewing) tobacco

- Obesity, as defined by BMI >30

- Known blood clotting disorder

- Current diagnosis of diabetes

- Be receiving antibiotic therapy for pre-existing condition or infection

- Have known personal or family history of keloid formation or hypertrophy

- Undergoing concurrent adjacent or congruent Liposuction procedures

- Concurrent use of fibrin sealants or other internal wound care devices

- Be currently taking systemic steroids or immunosuppressive agents

- Concurrent hernia repair greater than 6 cm and/or requiring the use of mesh

- Mini abdominoplasty (Abdominoplasty without umbilical transposition)

- Have known or suspected allergy or sensitivity to any test materials or reagents

- Be participating in any current clinical trial or have participated in any clinical trial within 30 days of enrollment in this study

- Pregnancy (30 days post-op)

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Cohera TissuGlu Surgical Adhesive
TissuGlu device used prior to closing of the flap in the abdominoplasty procedure.
Procedure:
Control- Standard of care
Control Arm- no TissuGlu device used. Standard abdominoplasty procedure followed.

Locations

Country Name City State
Germany University of Bonn Bonn
Germany Rosenpark Klinik Darmstadt
Germany Erich-Lexer-Klinik Freiburg

Sponsors (1)

Lead Sponsor Collaborator
Cohera Medical, Inc.

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary • Safety data will be gathered with respect to the number, timing, severity, duration and resolution of device and non-device related adverse events occurring among study subjects. Discharge, 14, 30, 60, 90 Day follow-up Yes
Secondary • Time to drain removal based upon a drain removal criteria of <30ml of fluid accumulation in a twenty four (24) hour period (Scevola et al, 2002; Momeni et al, 2008). Assessed at time of drain removal- Average 2 to 5 days post surgery. No
Secondary • Number of wound complications, seroma formation, wound dehiscence, infection, skin necrosis, hematoma Discharge, 14, 30, 60, 90 Day follow-up No
Secondary • Cumulative drainage volume for each patient Assessed at time of drain removal- Average 2-5 days post surgery. No
Secondary • Number of additional physician or clinic visits Discharge, 14, 30, 60, 90 Day follow-up No
Secondary • Number/type of additional procedures due to complications Discharge, 14, 30, 60, 90 Day follow-up No
Secondary • Evaluation of the delivery method/delivery device (Surgeon questionnaire) Questionnaire completed by the surgeon after the surgery rating ergonomics, visibility, ability to deliver the adhesive and overall satisfaction with the delivery method. Assessed at time of surgery/use of the device (Day 0) No
See also
  Status Clinical Trial Phase
Completed NCT03143959 - Functional Improvement With Abdominoplasty N/A
Active, not recruiting NCT04207047 - Histologic Evaluation of Tissue Following Lutronic System Exposure N/A
Active, not recruiting NCT04712331 - Effect of Abdominal Exercises and Russian Stimulation on The Abdominal Muscles Strength After Abdominoplasty N/A
Completed NCT02949778 - Quadratus Lumborum Block for Abdominoplasty Phase 4
Active, not recruiting NCT01026662 - In-vivo Analysis of a Fractional CO2 Laser System (eMatrixCO2) Intended for Treatment of Soft Tissue Phase 2/Phase 3
Withdrawn NCT03770195 - Registry Study for the Use of HEMOBLAST™ Bellows in Abdominoplasty
Terminated NCT03429556 - Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty Phase 2
Terminated NCT02302222 - The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing N/A
Recruiting NCT05939518 - Fluid Therapy and Glycocalyx Shedding During Moderate Surgery N/A
Active, not recruiting NCT05490602 - Comparison Study in Different Sutures Techniques in Reduction of Known Abdominoplasty Complications and Improving Patients' Post-operative Outcomes
Completed NCT01389635 - Abdominoplasty Under Epidural Anesthesia N/A
Recruiting NCT04670224 - Efficiency of the Quadratus Lumborum Block for Post-operative Analgesia in Abdominoplasty Surgery N/A
Recruiting NCT03190876 - Seroma Prevention After Body Contouring Procedures N/A
Recruiting NCT04787874 - Effect of Prehabilitation on Surgical Outcomes of Abdominally-based Plastic Surgery Procedures N/A
Completed NCT01604694 - Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty Phase 4
Withdrawn NCT02140385 - Role of Preservation of Scarpa's Fascia in Abdominoplasty N/A
Completed NCT04182880 - Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain Phase 2
Completed NCT03467724 - Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift N/A
Not yet recruiting NCT02930447 - Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty N/A
Enrolling by invitation NCT06043557 - Patient Satisfaction and Reflection on Drain Placement N/A